Cargando…

Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study

BACKGROUND: Women with current or previous drug use (WCPDU) have an increased risk of poor breast and cervical cancer outcomes. Screening is known to decrease the mortality of these common cancer forms, but screening participation has been sparsely investigated among women with drug dependency. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Garpenhag, Lars, Dahlman, Disa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936631/
https://www.ncbi.nlm.nih.gov/pubmed/36797737
http://dx.doi.org/10.1186/s12889-023-15236-3
_version_ 1784890270522802176
author Garpenhag, Lars
Dahlman, Disa
author_facet Garpenhag, Lars
Dahlman, Disa
author_sort Garpenhag, Lars
collection PubMed
description BACKGROUND: Women with current or previous drug use (WCPDU) have an increased risk of poor breast and cervical cancer outcomes. Screening is known to decrease the mortality of these common cancer forms, but screening participation has been sparsely investigated among women with drug dependency. The aim of this study was to assess participation in screening for breast and cervical cancer among WCPDU. METHODS: We recruited WCPDU to a survey study, from six opioid substitution treatment (OST) clinics and one needle exchange program (NEP) in Malmö, Sweden, and through the Drug Users Union in Stockholm, Sweden. The survey was constructed according to results from focus group discussions about cancer screening in a sample of women in OST. Survey data were analyzed using descriptive statistics. We analyzed associations between non-compliance to screening and healthcare contact (OST, NEP or none) by logistic regression analysis; unadjusted and adjusted for age, native language, housing situation, educational attainment and main source of income. RESULTS: A total of 298 women (median age 43 years) responded to the survey. The self-reported compliance with cancer screening recommendations was 29% for breast cancer screening and 41% for cervical cancer screening. Non-compliance with cervical cancer screening was associated with NEP participation in univariate but not multivariate analysis. We did not find an association between non-compliance with breast cancer screening and healthcare contact. Non-compliance with screening for cervical cancer was also associated with unstable housing in univariate and multivariate analyses, and inversely associated with increasing age in a univariate analysis. Non-compliance with breast cancer was associated with unstable housing in a univariate analysis, and inversely associated with not having Swedish as a native language in a multivariate analysis. CONCLUSION: The self-reported compliance with the national cancer screening programs for breast cancer and cervical cancer of WCPDU is notably lower than in the Swedish general population. Women with unstable housing seem to be particularly vulnerable to non-compliance with cancer screening. Interventions to minimize barriers to cancer screening are crucial to decrease the increased cancer morbidity and mortality among WCPDU. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15236-3.
format Online
Article
Text
id pubmed-9936631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99366312023-02-18 Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study Garpenhag, Lars Dahlman, Disa BMC Public Health Research BACKGROUND: Women with current or previous drug use (WCPDU) have an increased risk of poor breast and cervical cancer outcomes. Screening is known to decrease the mortality of these common cancer forms, but screening participation has been sparsely investigated among women with drug dependency. The aim of this study was to assess participation in screening for breast and cervical cancer among WCPDU. METHODS: We recruited WCPDU to a survey study, from six opioid substitution treatment (OST) clinics and one needle exchange program (NEP) in Malmö, Sweden, and through the Drug Users Union in Stockholm, Sweden. The survey was constructed according to results from focus group discussions about cancer screening in a sample of women in OST. Survey data were analyzed using descriptive statistics. We analyzed associations between non-compliance to screening and healthcare contact (OST, NEP or none) by logistic regression analysis; unadjusted and adjusted for age, native language, housing situation, educational attainment and main source of income. RESULTS: A total of 298 women (median age 43 years) responded to the survey. The self-reported compliance with cancer screening recommendations was 29% for breast cancer screening and 41% for cervical cancer screening. Non-compliance with cervical cancer screening was associated with NEP participation in univariate but not multivariate analysis. We did not find an association between non-compliance with breast cancer screening and healthcare contact. Non-compliance with screening for cervical cancer was also associated with unstable housing in univariate and multivariate analyses, and inversely associated with increasing age in a univariate analysis. Non-compliance with breast cancer was associated with unstable housing in a univariate analysis, and inversely associated with not having Swedish as a native language in a multivariate analysis. CONCLUSION: The self-reported compliance with the national cancer screening programs for breast cancer and cervical cancer of WCPDU is notably lower than in the Swedish general population. Women with unstable housing seem to be particularly vulnerable to non-compliance with cancer screening. Interventions to minimize barriers to cancer screening are crucial to decrease the increased cancer morbidity and mortality among WCPDU. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15236-3. BioMed Central 2023-02-16 /pmc/articles/PMC9936631/ /pubmed/36797737 http://dx.doi.org/10.1186/s12889-023-15236-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Garpenhag, Lars
Dahlman, Disa
Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title_full Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title_fullStr Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title_full_unstemmed Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title_short Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
title_sort participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936631/
https://www.ncbi.nlm.nih.gov/pubmed/36797737
http://dx.doi.org/10.1186/s12889-023-15236-3
work_keys_str_mv AT garpenhaglars participationinscreeningforbreastandcervicalcanceramongwomenwithcurrentorpreviousdruguseasurveystudy
AT dahlmandisa participationinscreeningforbreastandcervicalcanceramongwomenwithcurrentorpreviousdruguseasurveystudy